Manufacturers in India have rebranded Tramadol to Tafrodol to evade detection by customs officials at Nigeria’s ports and borders, a report by Enactafrica has revealed.
While the name change makes the drug look like Tramadol, Tafrodol contains two ingredients that should not be combined and can reportedly cause respiratory infection, coma and even instant death.
The rebranding comes shortly after several shipments of Tramadol were seized at Nigeria’s border posts.
In August 2020, the Nigeria Police Force, Nigerian Drug Law Enforcement Agency (NDLEA) and National Agency for Food and Drug Administration and Control (NAFDAC) intercepted 33 containers of Tramadol shipped from India worth N1.3 trillion in three different locations in Lagos.
Despite this, it is widely imported, smuggled and used – particularly among young people – for recreational and non-medical purposes. Health experts warn that this constitutes a threat to health security in the country.
Ahmed Yakasai, the former president of the Pharmaceutical Society of Nigeria, told ENACT that Tramadol’s rebranding for shipment into Nigeria had been ongoing for some time.
He said there was “a criminal collaboration between some pharmaceutical companies in Asia, especially India, and criminal gangs in Nigeria that import Tramadol in concealed brands into the country.” Examples include Tapentadol, an opioid medication used to treat severe pain.
Reasons for the rebranding include crackdowns by regulatory agencies over the past two years. In November 2018, 581 million Tramadol tablets, worth over N241 million and weighing about 118 metric tons, were seized in Lagos by NDLEA.
In June 2020, customs seized 379 packs of Tramadol worth over N56 million in Kaduna. These efforts have been complemented by restrictions on the movement of people and goods due to COVID-19.
As a result, the quantity of Tramadol in circulation across Nigeria has plummeted, causing demand and prices to rise.